Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP642 | DOI: 10.1530/endoabs.110.EP642

ECEESPE2025 ePoster Presentations Endocrine Related Cancer (100 abstracts)

A case of ectopic ACTH secretion caused by thymic neuroendocrine tumor (typical carcinoid) with metastasis to the breast after long-term remission

Aleksandra Zdrojowy-Welna 1 , Marek Bolanowski 1 , Aleksandra Jawiarczyk-Przybyłowska 1 , Anna Brona 1 , Joanna Syrycka 2 , Konrad Pawełczyk 3 & Justyna Kuliczkowska-Płaksej 1


1Wroclaw Medical University, Department and Clinic of Endocrinology and Internal Medicine, Wrocław, Poland; 2Affidea PET/CT Diagnostic Center, Wrocław, Poland; 3Lower Silesian Center of Oncology, Pulmonology and Hematology, Wrocław, Poland


JOINT604

Ectopic adrenocorticotropic hormone secretion (EAS) remains one of the most difficult challenges in endocrinology, representing between 9 and 18% of ACTH-dependent Cushing`s syndrome (CS) cases. Thymic neuroendocrine tumors (NETTs) are rare, mostly aggressive tumors, that are responsible for about 5-16% of EAS in recent series. We present a unique case of 34-year old female with EAS caused by NETT - typical carcinoid. First disease manifestation occurred in April 2016, when patient presented with severe hypercortisolism, diagnosed as EAS. First-line cross-sectional imaging studies were inconclusive, only 68Ga DOTA-TATE PET/CT revealed an oval lesion in the anterior mediastinum (1.9 x 1.3 cm) with subtle overexpression of somatostatin receptors (SUV max. 2.8). After initial treatment with steroid inhibitor (ketoconazole) the patient was sent to thoracoscopic removal of mediastinal tumor, in histopathological examination typical carcinoid without lymph node metastases was diagnosed. Postoperatively, transient adrenal insufficiency was observed with resolution of all symptoms. There was a diseases recurrence after 5 years of observation caused by a metastasis to the breast, shown in 68Ga DOTA-TATE PET/CT and confirmed with breast biopsy. Again, treatment with steroid inhibitor (metyrapone) and tumor resection were curative. Last disease relapse appeared 7 years after initial treatment (January 2023), with severe hypercortisolism treated with osilodrostat. There was a local recurrence in the mediastinum and a thoracoscopic surgery was performed with good clinical and biochemical effect. The patients remains under a careful follow-up. In conclusion, our case proves that NETTs with EAS might present in young patients with well-differentiated tumor in histopathological examination and severe, life-threatening hypercortisolism despite small size of the primary lesion. 68Ga-DOTATATE PET/CT is a very helpful tool to localize the tumor. There are only few descriptions of breast metastases from NETTs associated with EAS, our case was confirmed in biopsy and hormonally active. Finally, lifelong follow up should be performed despite complete remission after surgery.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches